Holland Capital successfully raises a new private equity fund of EUR 225 million after a swift fundraising period

 

Amsterdam/Düsseldorf, March 5, 2024 – After a fundraising period of five months, Holland Capital has established its new investment fund, Holland Capital Growth & Buy Out Fund V. There was significant interest from both existing and new investors, leading to the fund being oversubscribed. As a result, a first-and-final closing occurred at the hard cap of EUR 225 million. Investors in this new fund include (international) institutional parties, family offices, and entrepreneurs (many of whom are active in Healthcare and Technology). The fund is classified as an Article 8 fund under the Sustainable Finance Disclosure Regulation (SFDR).

The fund will continue its existing strategy

Holland Capital will deploy the capital for investments in medium-sized Dutch and German companies operating in the Healthcare, Technology, and Agrifood-Tech sectors. This aligns the investment strategy of this fund with its previous funds. With the SFDR Article 8 classification and the related ESG objectives of the fund, Holland Capital reaffirms its ambitions in this regard.

The fund manager aims to realize 15 to 20 platform investments in the coming years with the available capital. Holland Capital benefits from a continuous and robust lead flow in the mentioned sectors. The first planned investments are already in the final stages of ‘due diligence.’

As an active shareholder, Holland Capital adds value by providing not only capital but also knowledge, a network, and hands-on support in the professionalization of the organization and realization of buy-and-build strategies. Over the past 40 years, Holland Capital has supported over 180 entrepreneurs in growing their businesses. Ewout Prins and Hubert Verbeek, managing partners at Holland Capital, state, “We very much look forward to collaborating with entrepreneurs in this fund, creating value by supporting their companies to a next phase.”

Margot Engels, operational partner & CEO at Holland Capital, “We are grateful for the trust of our investors. The overwhelming enthusiasm is a testament to confidence in Holland Capital’s distinctive approach.”

About Holland Capital

For over 40 years, Holland Capital has responsibly and successfully invested in promising Dutch and German SMEs with growth ambitions. The team understands entrepreneurship and aims for an open, sustainable, and professional relationship with the management teams of the invested companies, with the shared goal of achieving growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare, Technology, and recently added Agrifood-Tech sectors. The team is familiar with the dynamics and opportunities in these sectors and has an extensive network.

Following this successful fundraising, Holland Capital’s total assets under management amount to EUR 500 million, and it currently holds 38 companies in its portfolio. For the fund manager, this marks the eleventh and largest fund since the organization’s establishment in 1981.

AMP Groep joins forces with Delta Logistiek

AMP Groep joins forces with Delta Logistiek  Houten, 10 January 2022 – Our participation AMP is taking the first step in its buy-and-build strategy with Delta Logistiek, enabled by Holland Capital. The joint entity can fully address its customers' needs trough an...

Holland Capital winner at the M&A Awards

Holland Capital winner at the M&A Awards Amsterdam, December 17, 2021 – Holland Capital wins an M&A Award again this year. Last Thursday, the best deals and dealmakers of 2021 were announced. Holland Capital was declared the winner of the six nominated...

Holland Capital wederom winnaar van een M&A Award

Holland Capital wederom winnaar van een M&A Award Amsterdam, 17 december 2021 – Holland Capital wint ook dit jaar weer een M&A Award. Afgelopen donderdag werden de beste deals en dealmakers van 2021 bekendgemaakt. Van de zes genomineerde investeerders in de...

Sirius Medical haalt tweede ronde van de serie A financiering op

Sirius Medical haalt tweede ronde van de serie A financiering opVoor de uitrol van commerciële activiteiten in de Verenigde Staten en het verder versnellen van innovatie Eindhoven, 14 december 2021 – Onze deelneming Sirius Medical, een pionier in tumor navigatie...

Sirius Medical announces second closing of A-round financing

Sirius Medical announces second closing of A-round financingCompany to accelerate U.S. expansion and innovation for next generation tumor navigation technology Eindhoven, Netherlands – December 14, 2021 –  Our portfolio company Sirius Medical, a leader in tumor...

YOEP Onderwijs en Zorg joins forces with Holland Capital

YOEP Onderwijs en Zorg joins forces with Holland Capital Amsterdam, December 3, 2021 – Holland Capital joins forces with YOEP Onderwijs en Zorg, a psychiatric organisation for children and youth that focuses on the interaction between family, education and care. With...

Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411

 

Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120

Contact
info@hollandcapital.nl